The plasma orexin-A levels in patients with MDD tended to be lower than those in the control group, although the difference failed to reach statistical significance after the Bonferroni correction was applied ( p =0.089).
1
0.0890
0.0890
The plasma orexin-A levels in patients with MDD tended to be lower than those in the control group, although the difference failed to reach statistical significance after the Bonferroni correction was applied ( p =0.089).